ZURICH–(BUSINESS WIRE)–Inositec, a pioneer in the development of life-saving small molecule drugs based on the natural compound inositol hexaphosphate (IP6), announced today that the U.S. Patent and Trademark Office (USPTO) has issued a patent covering its platform of inositol phosphate analogs and specifically INS-3001, an inhibitor of pathological soft tissue […]
Other News
Acceleron Receives Priority Medicines (PRIME) Designation from European Medicines Agency (EMA) for Sotatercept in Pulmonary Arterial Hypertension
First therapeutic to receive PRIME designation in pulmonary arterial hypertension since the EMA established the program in 2016 PRIME designation comes just three weeks after US FDA granted sotatercept Breakthrough Therapy designation CAMBRIDGE, Mass.–(BUSINESS WIRE)–Acceleron Pharma Inc. (Nasdaq: XLRN), a biopharmaceutical company dedicated to the discovery, development, and commercialization of […]
Sequana Medical Announces the Appointment of Dr. Oliver Gödje as Chief Medical Officer
GHENT, Belgium, May 04, 2020 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, today announces the appointment of Oliver Gödje, MD, PhD, as Chief Medical Officer, with immediate effect. Dr Gödje replaces Gijs Klarenbeek, MD, […]
CryoLife Reports First Quarter 2020 Financial Results
ATLANTA, April 30, 2020 /PRNewswire/ — First Quarter and Recent Business Highlights: Achieved total revenues of $66.4 million in the first quarter 2020 versus preliminary first quarter 2020 revenues of $65.5 million Total revenues decreased 2% and decreased 1% on a constant currency basis versus first quarter 2019 Excluding TMR, total revenues increased 1% and […]
The American Society For Preventive Cardiology (ASPC) Releases Official Scientific Statement On Continuity Of Care And Outpatient Management For Patients With And At High Risk For Cardiovascular Disease During The COVID-19 Pandemic
JACKSONVILLE, Fla., May 1, 2020 /PRNewswire/ — The American Society for Preventive Cardiology (ASPC) has released an official scientific statement titled: Continuity of Care and Outpatient Management for Patients With and At High Risk for Cardiovascular Disease During the COVID-19 Pandemic: A Scientific Statement. This official scientific statement, created by a team of […]
BioSig Resumes Clinical Activities with PURE EP System
Westport, CT, May 01, 2020 (GLOBE NEWSWIRE) — Clinical support staff to return to perform elective procedures at Texas Cardiac Arrhythmia Institute as of May 4, 2020 Company reconfirms its commitment to commercial installations this year BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing […]
Silk Road Medical Reports First Quarter 2020 Financial Results
SUNNYVALE, Calif., April 30, 2020 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended March 31, 2020. “As we continue through these challenging times, we are confident in […]
Abiomed Expands Product Portfolio with Acquisition of Cardiopulmonary Support Technology (ECMO) to Improve Outcomes for Patients
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (NASDAQ: ABMD), maker of the Impella heart pump, has acquired Breethe, developer of a novel extracorporeal membrane oxygenation (ECMO) system that will complement and expand Abiomed’s product portfolio to more comprehensively serve the needs of patients whose lungs can no longer provide sufficient oxygenation, including patients suffering from cardiogenic shock […]
Abiomed Announces Q4 FY 2020 Revenue of $207 Million and 28.1% Operating Margin
FY 2020 Annual Revenue of $841 Million, Up 9%, and 29.6% Operating Margin DANVERS, Mass.–(BUSINESS WIRE)–Apr. 30, 2020– Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies today reported fourth quarter fiscal 2020 revenue of $206.7 million compared to revenue of $207.1 million for the same period of fiscal 2019. For fiscal year 2020, […]
Amarin Reports First Quarter 2020 Financial Results and Provides Update on Operations
Total Revenue Increased 112% to $155 Million in First Quarter 2020 Compared to Prior Year Management to Host Conference Call at 7:30 a.m. ET Today DUBLIN, Ireland and BRIDGEWATER, N.J., April 30, 2020 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), today announced financial results for the quarter ended March 31, 2020 […]



